158 related articles for article (PubMed ID: 30556331)
1. Quality assessment of Ki67 staining using cell line proliferation index and stain intensity features.
Lanng MB; Møller CB; Andersen AH; Pálsdóttir ÁA; Røge R; Østergaard LR; Jørgensen AS
Cytometry A; 2019 Apr; 95(4):381-388. PubMed ID: 30556331
[TBL] [Abstract][Full Text] [Related]
2. Proliferation assessment in breast carcinomas using digital image analysis based on virtual Ki67/cytokeratin double staining.
Røge R; Riber-Hansen R; Nielsen S; Vyberg M
Breast Cancer Res Treat; 2016 Jul; 158(1):11-19. PubMed ID: 27283833
[TBL] [Abstract][Full Text] [Related]
3. Digital image analysis of Ki67 proliferation index in breast cancer using virtual dual staining on whole tissue sections: clinical validation and inter-platform agreement.
Koopman T; Buikema HJ; Hollema H; de Bock GH; van der Vegt B
Breast Cancer Res Treat; 2018 May; 169(1):33-42. PubMed ID: 29349710
[TBL] [Abstract][Full Text] [Related]
4. Ki-67 Proliferation Index in Breast Cancer as a Function of Assessment Method: A NordiQC Experience.
Røge R; Nielsen S; Riber-Hansen R; Vyberg M
Appl Immunohistochem Mol Morphol; 2021 Feb; 29(2):99-104. PubMed ID: 32168036
[TBL] [Abstract][Full Text] [Related]
5. Proliferation Tumour Marker Network (PTM-NET) for the identification of tumour region in Ki67 stained breast cancer whole slide images.
Joseph J; Roudier MP; Narayanan PL; Augulis R; Ros VR; Pritchard A; Gerrard J; Laurinavicius A; Harrington EA; Barrett JC; Howat WJ
Sci Rep; 2019 Sep; 9(1):12845. PubMed ID: 31492872
[TBL] [Abstract][Full Text] [Related]
6. Good staining quality ensuring the reproducibility of Ki67 assessment.
Wang YH; Lai CR; Lien HC; Hsu CY
J Clin Pathol; 2020 Jul; 73(7):413-417. PubMed ID: 31796636
[TBL] [Abstract][Full Text] [Related]
7. Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values.
Cserni G; Vörös A; Liepniece-Karele I; Bianchi S; Vezzosi V; Grabau D; Sapino A; Castellano I; Regitnig P; Foschini MP; Zolota V; Varga Z; Figueiredo P; Decker T; Focke C; Kulka J; Kaya H; Reiner-Concin A; Amendoeira I; Callagy G; Caffrey E; Wesseling J; Wells C
Breast; 2014 Jun; 23(3):259-63. PubMed ID: 24613255
[TBL] [Abstract][Full Text] [Related]
8. A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue.
Laurinavicius A; Plancoulaine B; Laurinaviciene A; Herlin P; Meskauskas R; Baltrusaityte I; Besusparis J; Dasevicius D; Elie N; Iqbal Y; Bor C
Breast Cancer Res; 2014; 16(2):R35. PubMed ID: 24708745
[TBL] [Abstract][Full Text] [Related]
9. Digital imaging in the immunohistochemical evaluation of the proliferation markers Ki67, MCM2 and Geminin, in early breast cancer, and their putative prognostic value.
Joshi S; Watkins J; Gazinska P; Brown JP; Gillett CE; Grigoriadis A; Pinder SE
BMC Cancer; 2015 Jul; 15():546. PubMed ID: 26205655
[TBL] [Abstract][Full Text] [Related]
10. A Comparison of Visual Assessment and Automated Digital Image Analysis of Ki67 Labeling Index in Breast Cancer.
Zhong F; Bi R; Yu B; Yang F; Yang W; Shui R
PLoS One; 2016; 11(2):e0150505. PubMed ID: 26928407
[TBL] [Abstract][Full Text] [Related]
11. Using cell nuclei features to detect colon cancer tissue in hematoxylin and eosin stained slides.
Jørgensen AS; Rasmussen AM; Andersen NKM; Andersen SK; Emborg J; Røge R; Østergaard LR
Cytometry A; 2017 Aug; 91(8):785-793. PubMed ID: 28727286
[TBL] [Abstract][Full Text] [Related]
12. Impact of Primary Antibody Clone, Format, and Stainer Platform on Ki67 Proliferation Indices in Breast Carcinomas.
Røge R; Nielsen S; Riber-Hansen R; Vyberg M
Appl Immunohistochem Mol Morphol; 2019; 27(10):732-739. PubMed ID: 31460869
[TBL] [Abstract][Full Text] [Related]
13. Prognostic comparison of the proliferation markers (mitotic activity index, phosphohistone H3, Ki67), steroid receptors, HER2, high molecular weight cytokeratins and classical prognostic factors in T₁₋₂N₀M₀ breast cancer.
Gudlaugsson E; Klos J; Skaland I; Janssen EA; Smaaland R; Feng W; Shao Z; Malpica A; Baak JP
Pol J Pathol; 2013 Apr; 64(1):1-8. PubMed ID: 23625593
[TBL] [Abstract][Full Text] [Related]
14. Relationship between the Ki67 index and its area based approximation in breast cancer.
Niazi MKK; Senaras C; Pennell M; Arole V; Tozbikian G; Gurcan MN
BMC Cancer; 2018 Sep; 18(1):867. PubMed ID: 30176814
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical double nuclear staining for cell-specific automated quantification of the proliferation index - A promising diagnostic aid for melanocytic lesions.
Brogård MB; Nielsen PS; Christensen KB; Georgsen JB; Wandler A; Lade-Keller J; Steiniche T
Pathol Res Pract; 2024 Mar; 255():155177. PubMed ID: 38330618
[TBL] [Abstract][Full Text] [Related]
16. ki67 nuclei detection and ki67-index estimation: a novel automatic approach based on human vision modeling.
Barricelli BR; Casiraghi E; Gliozzo J; Huber V; Leone BE; Rizzi A; Vergani B
BMC Bioinformatics; 2019 Dec; 20(1):733. PubMed ID: 31881821
[TBL] [Abstract][Full Text] [Related]
17. Ki67 and proliferation in breast cancer.
Pathmanathan N; Balleine RL
J Clin Pathol; 2013 Jun; 66(6):512-6. PubMed ID: 23436927
[TBL] [Abstract][Full Text] [Related]
18. The use of automated Ki67 analysis to predict Oncotype DX risk-of-recurrence categories in early-stage breast cancer.
Thakur SS; Li H; Chan AMY; Tudor R; Bigras G; Morris D; Enwere EK; Yang H
PLoS One; 2018; 13(1):e0188983. PubMed ID: 29304138
[TBL] [Abstract][Full Text] [Related]
19. A comparison of Ki 67 proliferative index in primary tumor and axillary metastatic lymph nodes with length of survival in patients with breast cancer.
Paksoy SE; Tasdelen I; Balaban AS; Ozkaya G; Tolunay S
Bratisl Lek Listy; 2013; 114(11):645-9. PubMed ID: 24236435
[TBL] [Abstract][Full Text] [Related]
20. Quantitative tumor heterogeneity assessment on a nuclear population basis.
Wessel Lindberg AS; Conradsen K; Larsen R; Friis Lippert M; Røge R; Vyberg M
Cytometry A; 2017 Jun; 91(6):574-584. PubMed ID: 28141908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
